Technology Assessment vs. Technology Appraisal—How to Strengthen the Science/Value Dichotomy with EU HTA?

Authors: Sandro Gsteiger, Heiner C. Bucher, James Ryan, Jörg Ruof

Source: Journal of Market Access & Health Policy, Vol 12, Iss 4, Pp 369-377 (2024)

Subject Terms: EU HTA regulation, EU HTA process, innovative health technologies, patient access, European access environment, HTA procedures, Public aspects of medicine, RA1-1270, Business, HF5001-6182

File Description: electronic resource

Relation: https://www.mdpi.com/2001-6689/12/4/28; https://doaj.org/toc/2001-6689

Access URL: https://doaj.org/article/b68b987cc3904c49b30155e3602490ea

Access in all areas? A roundup of developments in market access and health technology assessment: part 6

Authors: Annie Jullien Pannelay, Ramiro E Gilardino, Sreeram V Ramagopalan

Source: Journal of Comparative Effectiveness Research, Vol 14, Iss 3 (2025)

Subject Terms: eu hta regulation, health technology assessment, market access, nice, pico, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://doaj.org/toc/2042-6313

Access URL: https://doaj.org/article/e3fa3e5b8979451ea770c303239bd8b7

What is needed to successfully implement the EU HTA Regulation enabling broad patient access in Europe

Authors: Oriol Solà-Morales, Iga Lipska, Francois Meyer, Pier-Luigi Canonico, Herbert Altmann

Source: Global & Regional Health Technology Assessment, Vol 12, Iss 1 (2025)

Subject Terms: EU HTA Regulation, HTA, Implementation policy, Medical technology, R855-855.5

File Description: electronic resource

Relation: https://journals.aboutscience.eu/index.php/grhta/article/view/3354; https://doaj.org/toc/2284-2403; https://doaj.org/toc/2283-5733

Access URL: https://doaj.org/article/3ad683a7ef03469e9859b7d722e988ee

Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative

Authors: Zilke Claessens, Michiel Lammens, Liese Barbier, Isabelle Huys

Source: Journal of Market Access & Health Policy, Vol 12, Iss 3, Pp 144-157 (2024)

Subject Terms: Beneluxa initiative, cross-country collaboration, health technology assessment, International Horizon Scanning, pricing and reimbursement, EU HTA Regulation, Public aspects of medicine, RA1-1270, Business, HF5001-6182

File Description: electronic resource

Relation: https://www.mdpi.com/2001-6689/12/3/12; https://doaj.org/toc/2001-6689

Access URL: https://doaj.org/article/095fb859f18c4019a284c0368f75b13a

The EU Health Technology Assessment Regulation Halo Effect: Are Cross-Functional Teams Ready?

Authors: Sian Tanner, Rebecca Coady, Ana Lisica, Edel Falla, Anke van Engen

Source: Journal of Market Access & Health Policy, Vol 13, Iss 1, p 3 (2025)

Subject Terms: EU HTA regulation, EU HTA process, innovative health technologies, patient access, European Access Environment, HTA procedures, Public aspects of medicine, RA1-1270, Business, HF5001-6182

File Description: electronic resource

Relation: https://www.mdpi.com/2001-6689/13/1/3; https://doaj.org/toc/2001-6689

Access URL: https://doaj.org/article/f976f1b38bc1436882c4832fc0d5de4f

The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy

Authors: Elaine Julian, Oriol Solà-Morales, Maria João Garcia, Francine Brinkhuis, Mira Pavlovic, Carlos Martín-Saborido, Robin Doeswijk, Rosa Giuliani, Anne Willemsen, Wim Goettsch, Bernhard Wörmann, Urania Dafni, Heiner C. Bucher, Begoña Pérez-Valderrama, Renato Bernardini, Fabrizio Gianfrate, Carin A. Uyl-de Groot, Jörg Ruof

Source: Journal of Market Access & Health Policy, Vol 12, Iss 3, Pp 128-143 (2024)

Subject Terms: EU HTA, health policy, medical societies, clinical guidelines, best available evidence, health technology assessment, Public aspects of medicine, RA1-1270, Business, HF5001-6182

File Description: electronic resource

Relation: https://www.mdpi.com/2001-6689/12/3/11; https://doaj.org/toc/2001-6689

Access URL: https://doaj.org/article/f7baa0ed8a53416196beab87cb2d5619

EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity?

Authors: Volker Schuster

Source: Journal of Market Access & Health Policy, Vol 12, Iss 2, Pp 100-104 (2024)

Subject Terms: EU Health Technology Assessment (HTA), Joint Clinical Assessment (JCA), European Network for Health Technology Assessments, (EUnetHTA), EU HTA regulation, PICO scheme, Public aspects of medicine, RA1-1270, Business, HF5001-6182

File Description: electronic resource

Relation: https://www.mdpi.com/2001-6689/12/2/8; https://doaj.org/toc/2001-6689

Access URL: https://doaj.org/article/df64e9692b3942b6a7ba830f6167d14a

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?

Authors: Alejandra Castanon, Rebecca Sloan, Luisamanda Selle Arocha, Sreeram V Ramagopalan

Source: Journal of Comparative Effectiveness Research, Vol 13, Iss 6 (2024)

Subject Terms: eu hta, indirect comparison, jca, joint clinical assessment, real-world evidence, rwe, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://doaj.org/toc/2042-6313

Access URL: https://doaj.org/article/5f14e94285f84df4a7380f20621ea5fb

Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooks

Authors: Thomas Desmet, Maud Brijs, Frank Vanderdonck, Sven Tops, Steven Simoens, Isabelle Huys

Source: Frontiers in Pharmacology, Vol 15 (2024)

Subject Terms: health technology assessment, EU HTA regulation, perspectives, semi-structured interview, health policy, joint scientific consultation, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1369508/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/fa524562cdd5495dbb5b014329267d93

Access in all areas? a round up of developments in market access and health technology assessment: part 4

Authors: Alice Beattie, Catrin Treharne, Sreeram V Ramagopalan

Source: Journal of Comparative Effectiveness Research, Vol 6, Iss 13 (2024)

Subject Terms: aifa, agenzia italiana del farmaco, beneluxa initiative, eu hta, finose, health technology assessment, joint clinical assessment, managed entry agreements, market access, ned, new expensive drug, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://doaj.org/toc/2042-6313

Access URL: https://doaj.org/article/d3c9f59e8747475a96b2efec8b3342b7

Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European access academy

Authors: Elaine Julian, Mira Pavlovic, Oriol Sola-Morales, Fabrizio Gianfrate, Mondher Toumi, Heiner C. Bucher, Christian Dierks, Wolfgang Greiner, Peter Mol, Jean-François Bergmann, Tomas Salmonson, Ansgar Hebborn, Mathilde Grande, Antonella Cardone, Jörg Ruof

Source: Health Economics Review, Vol 12, Iss 1, Pp 1-15 (2022)

Subject Terms: EU HTA, Uncertainty, Comparators, Endpoints, Process, Clinical Trial Design, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/2191-1991

Access URL: https://doaj.org/article/49b7e3fc8c3140c6be0c21e052b00350

„Wer am AMNOG herumschraubt, sollte genau wissen, was er tut'

Authors: Dr. Marco Penske, Peter Stegmaier

Source: Monitor Versorgungsforschung, Vol 2022, Iss 05, Pp 14-18 (2022)

Subject Terms: amnog, vergleichstherapie, gkv-finanzstabilisierungsgesetz, zusatznutzenkategorien, eu-hta, gemeinsamer bundesausschuss, Public aspects of medicine, RA1-1270, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.monitor-versorgungsforschung.de/Abstracts/Kurzfassungen_2022/MVF-0522/MVF0522_Penske_AMNOG; https://doaj.org/toc/1866-0533; https://doaj.org/toc/2509-8381

Access URL: https://doaj.org/article/ecb67bbd6e3c46dc9e21f8d009eea435

How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?

Authors: Elaine Julian, Fabrizio Gianfrate, Oriol Sola-Morales, Peter Mol, Jean-François Bergmann, Tomas Salmonson, Ansgar Hebborn, Mathilde Grande, Jörg Ruof

Source: Health Economics Review, Vol 12, Iss 1, Pp 1-12 (2022)

Subject Terms: EU HTA, Europe’s Beating Cancer Plan, Comparators, Endpoints, Clinical trial design, Real world evidence, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/2191-1991

Access URL: https://doaj.org/article/2ba07948754a4eed9306acaeee9a8759